Sunday, June 14 |
07.15 - 08.15 |
||
|---|---|---|
BREAKFAST WORKSHOP |
ENDOTHELIAL PROGENITOR CELLS IN CARDIOVASCULAR DISEASE | Brown Hall |
| BREAKFAST WORKSHOP | OBSTRUCTIVE SLEEP APNOEA AND HYPERTENSION | Red Hall |
| BREAKFAST WORKSHOP | SETTING-UP A BLOOD PRESSURE CLINIC | Blue Hall |
| BREAKFAST WORKSHOP | THE NEW RISK FACTORS: "CIRCULATING" VERSUS "TISSUE" RISK FACTORS | Yellow Hall |
| BREAKFAST WORKSHOP | PHEOCROMOCYTOMA : AN UPDATE | White Hall |
| BREAKFAST WORKSHOP | TOTAL CARDIOVASCULAR RISK AND HIV | Green Hall 1 |
08.30 - 10.30 |
||
|---|---|---|
| Parallel Oral Session 4A | NON PHARMACOLOGICAL TREATMENT | Auditorium |
| Parallel Oral Session 4B | HEART | Blue Hall |
| Parallel Oral Session 4C | CLINICAL ASPECTS | Brown Hall |
| Parallel Oral Session 4D | GENETICS/MOLECULAR BIOLOGY | Green Hall 2 |
09.00 - 10.30 |
||
|---|---|---|
EDUCATIONAL SESSION Supported by an unrestricted educational grant from Boeheringer-Ingelheim |
CV EFFECTS OF HYPOBARIC HYPOXIA AT ALTITUDE: RELEVANCE FOR HT RESEARCH AND MANAGEMENT. A ROLE FOR THE RENIN-ANGIOTENSIN-ALDOSTER | White Hall |
JOINT SESSION OF ESH-ESC EUROPEAN STROKE CONFERENCE |
BLOOD PRESSURE MANAGEMENT IN PATIENTS WITH STROKE | Yellow Hall |
| TOPICAL WORKSHOP | NEW CARDIOVASCULAR DRUG DEVELOPMENT | Red Hall |
09.30 - 10.30 |
||
|---|---|---|
| CLINICAL CASE SESSION | HOW TO TREAT HYPERTENSION CRISIS | Green Hall 1 |
11.00 - 12.30 |
||
|---|---|---|
EDUCATIONAL SESSION Supported by an unrestricted grant from Boehringer-Ingelheim |
THE CHALLENGE OF CONTROL OF HYPERTENSION IN REAL LIFE | Red Hall |
| ESH WORKING GROUP MEEITNG | WORKING GROUP ON VASCULAR STRUCTURE AND FUNCTION | Green Hall 1 |
| JOINT SESSION OF ESH-IMS - INTERNATIONAL MENOPAUSE SOCIETY | HYPERTENSION, HRT AND CARDIOVASCULAR RISK IN POST-MENOPAUSAL WOMEN | Green Hall 2 |
| LATE-BREAKER SESSION 2 | LATE-BREAKER | Auditorium |
| Parallel Oral Session 5A | BLOOD PRESSURE MEASUREMENT | Blue Hall |
| Parallel Oral Session 5B | DIABETES AND METABOLIC SYNDROME | Yellow Hall |
| Parallel Oral Session 5C | SMALL VESSELS | Brown Hall |
| Parallel Oral Session 5D | RENAL ASPECTS | White Hall |
11.00-12.00 |
||
|---|---|---|
MINI-SYMPOSIUM FOR ITALIAN GPs Supported by Pfizer Italia |
LA CURA DEL PAZIENTE IPERTESO NELLA PRATICA CLINICA QUOTIDIANA. QUALI GARANZIE PER IL MEDICO DI MEDICINA GENERALE? | Green Hall 3 |
12.30 - 14.00 |
||
|---|---|---|
SATELLITE SYMPOSIUM Sponsored by Servier |
PRACTICAL QUESTIONS IN HYPERTENSION MANAGEMENT: INTERACTIVE DEBATE | Blue Hall |
| TEACHING SESSION | MANAGEMENT OF HYPERTENSION | Auditorium |
12.30-14.30 |
||
|---|---|---|
SYMPOSIUM OF THE INGENIOUS-HYPERCARE NETWORK |
INTEGRATING GENOMICS, CLINICAL RESEARCH AND CARE IN HYPERTENSION: REPORT FROM A EUROPEAN NETWORK | Brown Hall |
14.00-15.30 |
||
|---|---|---|
| Poster Session 16 | BLOOD PRESSURE MEASUREMENT | Ground Floor |
| Poster Session 17 | HEART | Ground Floor |
| Poster Session 18 | ENDOTHELIUM | Ground Floor |
| Poster Session 19 | RENAL ASPECTS | Ground Floor |
| Poster Session 20 | PREGNANCY | Ground Floor |
| Poster Session 21 | LARGE ARTERIES | Ground Floor |
| Poster Session 22 | DIABETES AND METABOLIC SYNDROME | Ground Floor |
| Poster Session 23 | METABOLISM AND ATHEROSCLEROSIS | Ground Floor |
| Poster Session 24 | EPIDEMIOLOGY | Ground Floor |
| Poster Session 25 | CLINICAL ASPECTS | Ground Floor |
| Poster Session 26 | CLINICAL TRIALS | Ground Floor |
| Poster Session 27 | THERAPEUTIC ASPECTS | Ground Floor |
| Poster Session 28 | ENDOCRINE ASPECTS | Ground Floor |
| Poster Session 29 | BASIC PHARMACOLOGICAL ASPECTS | Ground Floor |
| Poster Session 30 | RENIN ANGIOTENSIN AND OTHER VASOACTIVE SUBSTANCES | Ground Floor |
14.30 - 15.30 |
||
|---|---|---|
| "HOW TO" SESSION | HOW TO ASSESS ARTERIAL STIFFNESS | Green Hall 1 |
| "HOW TO" SESSION | HOW TO INTERPRET GENETIC ASSOCIATION STUDIES | Green Hall 3 |
"HOW TO" SESSION |
HOW TO ASSESS BAROREFLEX SENSITIVITY | Green Hall 2 |
15.00 - 17.00 |
||
|---|---|---|
| TOPICAL WORKSHOP | COGNITIVE FUNCTION, DEMENTIA AND HYPERTENSION | Brown Hall |
15.30 - 17.00 |
||
|---|---|---|
EDUCATIONAL SESSION Supported by an unrestricted educational grant from AstraZeneca |
RENIN-ANGIOTENSIN SYSTEM BLOCKADE AS A BASIS FOR COMBINATION THERAPY | Red Hall |
| ESH WORKING GROUP MEETING | WORKING GROUP ON OBESITY | Green Hall 1 |
| Parallel Oral Session 6A | CLINICAL TRIALS | Auditorium |
| Parallel Oral Session 6B | PREGNANCY | Blue Hall |
| Parallel Oral Session 6C | LARGE ARTERIES | Yellow Hall |
| Parallel Oral Session 6D | RENIN ANGIOTENSIN AND OTHER VASOACTIVE SUBSTANCES | White Hall |
15.30-17.30 |
||
|---|---|---|
| ESH WORKING GROUP MEETING | WORKING GROUP ON BLOOD PRESSURE AND HEART RATE VARIABILITY | Green Hall 2 |
16.00-17.00 |
||
|---|---|---|
MEET THE EXPERT SESSION |
HOW TO READ CLINICAL TRIALS | Green Hall 3 |
17.00 - 18.30 |
||
|---|---|---|
| PLENARY SESSION | GUIDELINES OF HYPERTENSION MANAGEMENT REVISITED IN 2009 - ESH POSITION STATMENT |